EMA Recommends Extending Indications for Decitabine / Cedazuridine By Ogkologos - May 29, 2026 246 0 Facebook Twitter Google+ Pinterest WhatsApp New indication concerns a combination with venetoclax for the treatment of adult patients with newly diagnosed AML Source RELATED ARTICLESMORE FROM AUTHOR Non-pharmacological interventions – are they important to patients with cancer? Two novel bispecific antibodies in combination with chemotherapy show efficacy in neuroendocrine carcinomas Sacituzumab tirumotecan plus pembrolizumab significantly prolongs progression-free survival in advanced non-small cell lung cancer MOST POPULAR Meet the teams tackling 5 challenges in children’s and young people’s... March 18, 2021 Genomic and Immunophenotypic Heterogeneity of Acquired Resistance to Immune Checkpoint Inhibitors... January 30, 2024 A New FDA Approval Furthers the Role of Genomics in Cancer... July 8, 2020 FDA Approves Atezolizumab for BRAF V600 Mutation Positive Unresectable or Metastatic... August 3, 2020 Load more HOT NEWS A winding journey into the world of children’s and young people’s... Researchers Have Harnessed a Compound from a Common Plant Called Feverfew... Tips from Your Cancer Care Team – Coping with Treatment During... Adjusting to the Challenges of Life After Cancer: An Expert Perspective
